Heat Shock Protein 60 (HSP60) is ubiquitous and highly conserved, being present in eukaryotes and prokaryotes, including pathogens. This chaperonin is typically considered a mitochondrial protein but it is also found in other intracellular sites, extracellularly and in circulation. HSP60 is an indispensable component of the Chaperoning System and plays a key role in protein quality control, preventing off-pathway folding events and refolding misfolded proteins. This makes HSP60 a putative therapeutic agent for neurodegenerative diseases associated with aggregation of misfolded proteins, for example, Alzheimer’s Disease. We produced and purified recombinant human HSP60 and investigated the effects of its monomeric and tetradecameric forms onAmyloid-β aggregation. In addition, we induced oligomerization of HSP60 monomers by means of ATP. We measuredHSP60 stability in relation to degree of oligomerization. The structural stability of the HSP60 forms were also investigated by differential scanning calorimetry and isothermal titration calorimetry. The protein purified mainly appears in multimeric forms with a large fraction in dimers and monomers. We observed that Hsp60 is less stable in its monomeric form, but is more active in inhibiting the fibrillogenesis of beta amyloid peptide.
The molecular anatomy of human Hsp60 and its effects on Amyloid-β peptide
Celeste Caruso Bavisotto
;Antonella Marino Gammazza;Fabio Bucchieri;Claudia Campanella;Francesco Cappello
Abstract
Heat Shock Protein 60 (HSP60) is ubiquitous and highly conserved, being present in eukaryotes and prokaryotes, including pathogens. This chaperonin is typically considered a mitochondrial protein but it is also found in other intracellular sites, extracellularly and in circulation. HSP60 is an indispensable component of the Chaperoning System and plays a key role in protein quality control, preventing off-pathway folding events and refolding misfolded proteins. This makes HSP60 a putative therapeutic agent for neurodegenerative diseases associated with aggregation of misfolded proteins, for example, Alzheimer’s Disease. We produced and purified recombinant human HSP60 and investigated the effects of its monomeric and tetradecameric forms onAmyloid-β aggregation. In addition, we induced oligomerization of HSP60 monomers by means of ATP. We measuredHSP60 stability in relation to degree of oligomerization. The structural stability of the HSP60 forms were also investigated by differential scanning calorimetry and isothermal titration calorimetry. The protein purified mainly appears in multimeric forms with a large fraction in dimers and monomers. We observed that Hsp60 is less stable in its monomeric form, but is more active in inhibiting the fibrillogenesis of beta amyloid peptide.File | Dimensione | Formato | |
---|---|---|---|
CCB Abstract Poster HSP60.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
963.28 kB
Formato
Adobe PDF
|
963.28 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.